"サノフィ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonSanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella - Fierce...
- Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella FiercePharma
- France warns US buyer of Sanofi division of penalties for shifting production abroad The Guardian
- CD&R Nears Sanofi OTC Deal After Signing With Government Yahoo Finance
- Sanofi deal offers only partial headache relief Financial Times
- Sanofi in exclusive talks with CD&R over sale of $17 billion Opella Reuters
- Sanofi pursues sale of France's leading painkiller to US investment fund after controversy FRANCE 24 English
- Deal to sell Sanofi unit to US fund deals new blow to French govt | Daily Sabah Daily Sabah
- Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare GlobeNewswire
- Sanofi confirms €16 billion sale of painkiller Doliprane to US investors RFI English
M&A deals roundup: Expedia, Sanofi, Zuora, Forward Air and more - Seeking Alpha
M&A deals roundup: Expedia, Sanofi, Zuora, Forward Air and more Seeking Alpha
French government 'must block the sale' of Sanofi's Doliprane painkiller to U.S. private equity, ...
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources - Reuters
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources Reuters
Sanofi moves ahead with CD&R deal for stake in consumer business - BioPharma Dive
Sanofi moves ahead with CD&R deal for stake in consumer business BioPharma Dive
Emmanuel Macron's Private-Equity Migraine Needs New Pills - Bloomberg
Emmanuel Macron's Private-Equity Migraine Needs New Pills Bloomberg
Sanofi’s Sarclisa approved as first-line for transplant-ineligible multiple myeloma patients - 2 ...
Sanofi’s Sarclisa approved as first-line for transplant-ineligible multiple myeloma patients 2 Minute Medicine
France takes stake in Sanofi unit as part of €16bn sale to CD&R - Financial Times
France takes stake in Sanofi unit as part of €16bn sale to CD&R Financial Times
Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit - BioSpace
Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit BioSpace
Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale - Yahoo Finance
Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale Yahoo Finance
Private Equity Heats Up With Sanofi's Massive Sale - Finimize
Recon: Sanofi in talks to sell its consumer business Opella; Novo’s Rybelsus cut heart risks in P...
Recon: Sanofi in talks to sell its consumer business Opella; Novo’s Rybelsus cut heart risks in Phase III trial Regulatory Focus
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals - BioS...
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals BioSpace
PAI Partners to Raise Offer for Sanofi’s Consumer Unit - Yahoo Finance
PAI Partners to Raise Offer for Sanofi’s Consumer Unit Yahoo Finance
Sanofi pursues sale of painkiller after political controversy - Medical Xpress
Sanofi pursues sale of painkiller after political controversy Medical Xpress
Goldman, Citi Among 22 Banks on CD&R’s Buyout of Sanofi Unit - Yahoo Finance
Goldman, Citi Among 22 Banks on CD&R’s Buyout of Sanofi Unit Yahoo Finance
PAI Partners to Raise Offer for Sanofi’s Consumer Unit - Bloomberg
PAI Partners to Raise Offer for Sanofi’s Consumer Unit Bloomberg
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business - ...
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business Yahoo Finance
Doliprane-maker Sanofi confirms exclusive talks with US firm CD&R - Euronews
Doliprane-maker Sanofi confirms exclusive talks with US firm CD&R Euronews
Sanofi 'surprised' by PAI Partners' raised bid for Opella unit - Reuters
Sanofi 'surprised' by PAI Partners' raised bid for Opella unit Reuters
Goldman, Citi Among 22 Banks on CD&R’s Buyout of Sanofi Unit - Bloomberg
Goldman, Citi Among 22 Banks on CD&R’s Buyout of Sanofi Unit Bloomberg
Sanofi workers in France to strike over sale of consumer health unit, union official says - Reuters
Sanofi workers in France to strike over sale of consumer health unit, union official says Reuters
CD&R Nears Sanofi OTC Deal After Signing With Government - Bloomberg
CD&R Nears Sanofi OTC Deal After Signing With Government Bloomberg
Sanofi Inks $326M Radiopharma Deal With Orano - BioSpace
Sanofi (EPA:SAN) shareholders have earned a 7.7% CAGR over the last five years - Simply Wall St
Sanofi (EPA:SAN) shareholders have earned a 7.7% CAGR over the last five years Simply Wall St
Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend - Yahoo Finance
Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend Yahoo Finance
Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines - Gl...
Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines GlobeNewswire
Sanofi’s $17bn sale of Opella to US investors advances following government deal - Pharmaceutical...
Sanofi’s $17bn sale of Opella to US investors advances following government deal Pharmaceutical Technology
Sanofi deal jitters imperil stock’s rebound - Private Equity News
Sanofi deal jitters imperil stock’s rebound Private Equity News
Sanofi returns to Orano with €300M for new radioligand 'pioneer' - Fierce Biotech
Sanofi returns to Orano with €300M for new radioligand 'pioneer' Fierce Biotech
Sanofi in talks with CD&R to sell 50% stake in Opella for €16bn - World Pharmaceutical Frontiers
Sanofi in talks with CD&R to sell 50% stake in Opella for €16bn World Pharmaceutical Frontiers
Sanofi unit bid: Private group lifts offer, pledging to save French jobs - Euronews
Sanofi unit bid: Private group lifts offer, pledging to save French jobs Euronews
Amid strike threat, Sanofi promises consumer health group will stay 'anchored' in France - Fierce...
Amid strike threat, Sanofi promises consumer health group will stay 'anchored' in France FiercePharma
Sanofi, expanding in radiopharma, strikes a joint venture deal - BioPharma Dive
Sanofi, expanding in radiopharma, strikes a joint venture deal BioPharma Dive
Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend - Bloomberg
Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend Bloomberg
Trending tickers: Boeing, Sanofi, SAP, Nokia and Tata Consumer Products - Yahoo Finance UK
Trending tickers: Boeing, Sanofi, SAP, Nokia and Tata Consumer Products Yahoo Finance UK
Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&D - Sanofi
Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&D Sanofi
Sanofi : A support level that should be taken advantage of - Marketscreener.com
Sanofi : A support level that should be taken advantage of Marketscreener.com
France considering stake in Sanofi's Opella, minister says - Reuters
France considering stake in Sanofi's Opella, minister says Reuters
Sanofi enters exclusive talks with CD&R over consumer business stake sale - Private Equity News
Sanofi enters exclusive talks with CD&R over consumer business stake sale Private Equity News
Sanofi, Denali Abandon Mid-Stage Multiple Sclerosis Study on Disappointing Data - BioSpace
Sanofi, Denali Abandon Mid-Stage Multiple Sclerosis Study on Disappointing Data BioSpace
Sanofi joins rivals investing in nuclear cancer treatment - Financial Times
Sanofi joins rivals investing in nuclear cancer treatment Financial Times
Sanofi, CD&R partner to support Opella’s growth in consumer health care - Drug Store News
Sanofi, CD&R partner to support Opella’s growth in consumer health care Drug Store News
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal - BioSpace
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal BioSpace
France seeks job guarantees from Sanofi over Doliprane painkiller production - Reuters
France seeks job guarantees from Sanofi over Doliprane painkiller production Reuters
Every Breath Matters: Addressing Unmet Needs in Respiratory Care - Sanofi
Every Breath Matters: Addressing Unmet Needs in Respiratory Care Sanofi
Sanofi in talks to sell 50% stake in consumer health business to CD&R - Reuters
Sanofi in talks to sell 50% stake in consumer health business to CD&R Reuters
RSI Alert: Sanofi (SNY) Now Oversold - Nasdaq
Sanofi’s Dulcolax flushes away taboos in Pooping Princesses campaign - MM+M Online
Sanofi’s Dulcolax flushes away taboos in Pooping Princesses campaign MM+M Online
Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella - MarketWatch
Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella MarketWatch
CD&R nears deal to buy Sanofi's consumer unit for $16 bln, source says - Reuters
CD&R nears deal to buy Sanofi's consumer unit for $16 bln, source says Reuters
Sanofi may have found a buyer for its consumer health business - BioPharma Dive
Sanofi may have found a buyer for its consumer health business BioPharma Dive
Press Release: Sanofi in discussions to sell a controlling stake in Opella - GlobeNewswire
Press Release: Sanofi in discussions to sell a controlling stake in Opella GlobeNewswire
Sanofi invests in new radioligand partner Orano Med, buying 16% stake for €300M - Endpoints News
Sanofi invests in new radioligand partner Orano Med, buying 16% stake for €300M Endpoints News
Regeneron and Sanofi’s Dupixent Tipped to Dominate COPD Biologics Market - BioSpace
Regeneron and Sanofi’s Dupixent Tipped to Dominate COPD Biologics Market BioSpace
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung' - Reuters
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung' Reuters
Sanofi collaboration to advance innovative radioligand therapies - European Pharmaceutical Review
Sanofi collaboration to advance innovative radioligand therapies European Pharmaceutical Review
PAI Partners Submits Improved Bid on Sanofi's Consumer Unit - MarketWatch
PAI Partners Submits Improved Bid on Sanofi's Consumer Unit MarketWatch
Sanofi and Orano Med link for radioligand therapy development - Yahoo Finance
Sanofi and Orano Med link for radioligand therapy development Yahoo Finance
Meharry receives investment from Sanofi to increase diversity in clinical studies - tntribune.com
Meharry receives investment from Sanofi to increase diversity in clinical studies tntribune.com
France warns it could block €15.5bn Sanofi consumer health deal - Financial Times
France warns it could block €15.5bn Sanofi consumer health deal Financial Times
Sanofi and NUPCO sign the offtake agreement - ZAWYA
Global markets live: Sanofi, Eni, Boeing, Cigna, AT&T... - Marketscreener.com
Global markets live: Sanofi, Eni, Boeing, Cigna, AT&T... Marketscreener.com
A setback for the Denali-Sanofi partnership - STAT
Sanofi Gets Binding Bids from CD&R, PAI for Consumer Arm - Bloomberg
Sanofi Gets Binding Bids from CD&R, PAI for Consumer Arm Bloomberg
Sanofi (NASDAQ:SNY) Eyes Divestiture of Consumer Health Business, Opella, to U.S. Firm - TipRanks
Sanofi (NASDAQ:SNY) Eyes Divestiture of Consumer Health Business, Opella, to U.S. Firm TipRanks
Sanofi Sells Majority Stake In Opella To CD&R, French State - Law360
Sanofi Sells Majority Stake In Opella To CD&R, French State Law360
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration - Business Wire
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration Business Wire
CD&R is said to near Sanofi OTC deal after commitments to France (NASDAQ:SNY) - Seeking Alpha
CD&R is said to near Sanofi OTC deal after commitments to France (NASDAQ:SNY) Seeking Alpha
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Po...
France doesn’t want to veto sale of paracetamol-maker to US fund, for now - POLITICO Europe
France doesn’t want to veto sale of paracetamol-maker to US fund, for now POLITICO Europe
Sanofi pursues sale of painkiller after political controversy - El Paso Inc.
Sanofi pursues sale of painkiller after political controversy El Paso Inc.
CD&R makes Rs 2,983 cr offer for 26% stake in Sanofi Consumer Healthcare - Business Standard
CD&R makes Rs 2,983 cr offer for 26% stake in Sanofi Consumer Healthcare Business Standard
Sanofi’s rare disease drug finds yet another home - BioPharma Dive
Sanofi’s rare disease drug finds yet another home BioPharma Dive
Amid push to redefine itself, Sanofi names new chief scientific officer - STAT
Amid push to redefine itself, Sanofi names new chief scientific officer STAT
Sanofi enters talks with private equity firm to sell controlling stake in consumer health unit Op...
Sanofi enters talks with private equity firm to sell controlling stake in consumer health unit Opella FiercePharma
Sanofi Sells Controlling Stake in Opella to CD&R with Job Guarantees - Industry Leaders Magazine
Sanofi Sells Controlling Stake in Opella to CD&R with Job Guarantees Industry Leaders Magazine
Sanofi invites patients to ‘Rediscover MS’ with new educational site on disease progression - Fie...
Sanofi invites patients to ‘Rediscover MS’ with new educational site on disease progression FiercePharma
Sanofi pursues sale of painkiller after political controversy - The Daily Record
Sanofi pursues sale of painkiller after political controversy The Daily Record
Why Smoldering Neuroinflammation Must Be Part of the Discussion in MS - Sanofi
Why Smoldering Neuroinflammation Must Be Part of the Discussion in MS Sanofi
Sanofi aims to sign consumer health sales pact with CD&R shortly, Bloomberg says - TipRanks
Sanofi aims to sign consumer health sales pact with CD&R shortly, Bloomberg says TipRanks
Sanofi in exclusive talks for sale of 50% controlling stake in Opella to CD&R for €16B - Seeking ...
Sanofi in exclusive talks for sale of 50% controlling stake in Opella to CD&R for €16B Seeking Alpha
Sanofi : The Doliprane case - Marketscreener.com
Sanofi : The Doliprane case Marketscreener.com
Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln - Reuters
Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln Reuters
It’s Time to Look Beyond the Bleed - Sanofi
Sanofi's tolebrutinib drug delays progressive MS by 31% in trial - Reuters
Sanofi's tolebrutinib drug delays progressive MS by 31% in trial Reuters
Sanofi & Orano Med Join Forces To Advance Targeted Alpha Therapies In Oncology - Contract Pharma
Sanofi & Orano Med Join Forces To Advance Targeted Alpha Therapies In Oncology Contract Pharma
French minister says block to Sanofi deal is still 'on the table' - Euronews
French minister says block to Sanofi deal is still 'on the table' Euronews
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI - Marketscreener.com
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI Marketscreener.com